— Know what they know.
Not Investment Advice

DGX

Quest Diagnostics Incorporated
1W: -2.2% 1M: -3.5% 3M: +9.1% YTD: +12.9% 1Y: +17.9% 3Y: +55.5% 5Y: +73.9%
$195.26
+1.10 (+0.57%)
After Hours: $200.22 (+4.96, +2.54%)
NYSE · Healthcare · Medical - Diagnostics & Research · $21.7B · Alpha Radar Neutral · Power 47
Smart Money Score
Bullish 75
Insider+$50.4M
Congress
ETF Holdings
Key Statistics
Market Cap$21.7B
52W Range157.2-213.5
Volume853,206
Avg Volume949,066
Beta0.63
Dividend$3.20
Analyst Ratings
13 Buy 18 Hold 3 Sell
Consensus Hold
Company Info
CEOJames E. Davis
Employees55,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1996-12-17
500 Plaza Drive
Secaucus, NJ 07094
US
973 520 2700
About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Recent Insider Trades

NameTypeSharesPriceDate
WENTWORTH TIMOTHY C A-Award 215 2026-03-09
WENTWORTH TIMOTHY C 0 2026-03-09
Doherty Catherine T. S-Sale 5,558 $206.21 2026-03-05
PREVOZNIK MICHAEL E S-Sale 3,878 $206.21 2026-03-05
Plewman Patrick S-Sale 2,855 $206.21 2026-03-05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms